Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

411

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Ocular HypertensionOpen-angle Glaucoma

Interventions

DRUG

Timolol maleate Ophthalmic Solution 0.5% BID

1 drop BID, AM/PM, OU

DRUG

AR-13324 Ophthalmic Solution 0.02%

1 drop once daily (QD), PM, OU

OTHER

Placebo

1 drop QD, AM, OU

Trial Locations (1)

Aerie Pharmaceuticals, Bedminster